Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Launches
Pharma
Novartis builds momentum with new drug launches
Novartis CEO Vas Narasimhan acknowledged that the company could have made its recent $23 billion U.S. investment plan sooner.
Angus Liu
Apr 29, 2025 10:52am
Bayer wins appeal in case of ‘warming’ market for Eylea launch
Apr 29, 2025 9:00am
As Pfizer bows out, CSL keeps hemophilia gene therapy hopes alive
Apr 11, 2025 10:32am
Merz makes Salma Hayek Pinault ambassador for skin device
Apr 9, 2025 6:55am
Artis BioSolutions launches with acquisition of Landmark Bio
Apr 2, 2025 10:22am
Akebia sketches out pivotal Vafseo study in nondialysis patients
Mar 13, 2025 3:28pm
.jpg?VersionId=BprDjbYc4Rl7XufFm1.Y4YdAEiJvlovL)
.jpg?VersionId=rKfXgG6zD0qa2yVWv55s6YEJujkOSVMg)